State of the Science Summit: Treatment of Breast Cancer

 

Chair: Lee Schwartzberg, MD, FACP

Institution: West Cancer Center and Research Institute

Date: Tuesday, October 29th 2019 | 5:00pm – 9:00pm

Location: Hilton Memphis | 939 Ridge Lake Blvd, Memphis, TN 38120

Participants:

  • Lee Schwartzberg, MD, FACP | West Cancer Center and Research Institute
  • Michael Berry, MD| West Cancer Center and Research Institute
  • Noam VanderWalde, MD, MS | West Cancer Center and Research Institute
  • Gregory Vidal, MD, PhD | West Cancer Center and Research Institute
  • Bradley G. Somer, MD | West Cancer Center and Research Institute
  • Kurt W. Tauer, MD, FACP | West Cancer Center and Research Institute

 

To register, please visit: onclive.com/meetings/soss ​

Preliminary Meeting Agenda

Time

Presentations

Speaker

Duration

5:00-5:30

Arrivals and Registration

30 min

5:30-5:40

Welcome

10 min

5:40-5:55

Management of the Axilla

Berry

15 min

5:55-6:10

Role of Radiation in early Breast Cancer

VanderWalde

15 min

6:10-6:30

HR+/HER2- Early Stage Disease

Schwartzberg

20 min

6:30-6:45

Peer Exchange:  HR+ Case Discussions

Moderator:

Schwartzberg

Panel:

Vidal, Berry, VanderWalde

15 min

6:45-7:25

Networking Reception: Food & Drinks

40 min

7:25-7:50

Updates in Metastatic HR+/HER2-

·         CDK 4/6 Inhibitors: MONALEESA 2, 3, 7 (ASCO Updates), PALOMA-3, MONARCH

·         PI3K Inhibitors

  • PATINA

Schwartzberg

25 min

7:50-8:15

Novel Approaches to HER2-Positive Breast Cancer

  • KATHERINE vs. APHINITY
  • ExteNET
  • Metastatic: NALA trial
  • SOPHIA
Vidal 25 min

8:15-8:40

Novel Approaches for Metastatic Triple-Negative Breast Cancer

  • Immunotherapy (IMPASSION 130)
  • ADCs
  • PARP Inhibitors for BRCA1/2-mutation (Olympiad, EMBRCA, TOPACIO, MEDIOLA)
Schwartzberg 25 min

8:40-8:55

Peer Exchange:  Panel Discussion Q&A

Moderator:

Vidal

Panel:

Tauer, Somer, Schwartzberg

15 min

8:55-9:00

Concluding Remarks

5 min

 

 

X